Alex Schwartz Initiated (ANAB) at Strong Buy and Held Target at $50 on, Feb 21st, 2024
Alex Schwartz of Stifel, Initiated "AnaptysBio, Inc." (ANAB) at Strong Buy and Held Target at $50 on, Feb 21st, 2024.
Alex has made no other calls on ANAB in the last 4 months.
There are 3 other peers that have a rating on ANAB. Out of the 3 peers that are also analyzing ANAB, 2 agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Nierengarten of "Wedbush" Reiterated at Hold and Held Target at $20 on, Wednesday, November 29th, 2023
- Eliana Merle of "UBS" Maintained at Hold with Decreased Target to $21 on, Thursday, November 2nd, 2023
This is the rating of the analyst that currently disagrees with Alex
- Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $80 on, Friday, February 16th, 2024
Contributing Sources